GlassScriptPhysician profile
Claudiu A Cimpean
NPI 1861483844
$17,721.57
in general payments reported to CMS, 2019-2025
18 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $47.74 · 2021: $5,746 · 2022: $8,540 · 2023: $783 · 2024: $682 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,411 · Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,411.25 |
| Food and Beverage | $1,344.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,704.60 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $2,247.62 | 2019-2025 | Phasix Mesh |
| Boston Scientific Corporation | $199.44 | 2019-2024 | Spyglass Discover |
| Kci USA, INC. | $90.44 | 2019 | |
| Conmed Corporation | $89.28 | 2021 | |
| Smith+Nephew, INC. | $88.48 | 2019-2025 | Collagenase Santyl |
| Tela Bio, INC. | $60.57 | 2024 | Ovitex 2s |
| Mallinckrodt Enterprises LLC | $42.50 | 2019 | |
| Allergan, INC. | $34.61 | 2021 | |
| Olympus America INC. | $28.73 | 2019-2020 | |
| Csl Behring | $26.29 | 2019 | |
| Tei Biosciences INC | $19.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.87 | 2020 | |
| Coloplast Corp | $16.17 | 2023 | Sensura Mio |
| Braintree Laboratories, INC. | $15.47 | 2023 | Sutab |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $15.25 | 2025 | Voquezna |
| Osiris Therapeutics INC. | $13.01 | 2019 | |
| Shire North American Group INC | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudiu Cimpean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.